Search


Current filters:



Clear current filters  or Add more filters

View Option



Results 1-10 of 19 (Search time: 0.004 seconds).

  Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study) (Journal article)

  The epsilon 2 and 4 alleles of apolipoprotein E and ischemic vascular events in the Greek population--implications for the interpretation of similar studies (Journal article)

  Targeting vascular risk in patients with metabolic syndrome but without diabetes (Journal article)

  The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol (Journal article)

  The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study (Journal article)

  The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate (Journal article)

  The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial sampling (Journal article)

  Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance (Journal article)

  The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions (Journal article)

  Effect of statins and ACE inhibitors alone and in combination on clinical outcome in patients with coronary heart disease (Journal article)